Mogamulizumab – March 2025

• Brand names:
  • Poteligeo®
• Pharmaceutical Company:
  • KYOWA KIRIN AUSTRALIA PTY LTD
• Condition/Indication: Cutaneous T-cell lymphoma (CTCL)
• Meeting Date: March 2025
• Public Summary Document (PSD) March 2025 September 2025 PBAC Meetings - (PDF 907KB)
• Public Summary Document (PSD) March 2025 September 2025 PBAC Meetings - (Word 402KB)

Related Public Summary Documents

• Mogamulizumab – September 2025